Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say
The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.
Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics
US Radiology Specialists backer Welsh, Carson, Anderson & Stowe blasted the proposed order Friday, labeling it as symbolic and politically motivated.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
FDA regulator examines AI's growing influence in cardiology
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.

Radiology data analytics vendor Quinsite raises $5.5M in series A financing

The funds will fuel growth initiatives and expansion in other specialties such as pathology, anesthesiology, orthopedics and emergency medicine.

American College of Radiology 2023 Annual Meeting

William Herrington elected ACR president, plus more news from the college’s 2023 annual meeting

Ezequiel Silva, MD, received the 2023 William T. Thorwarth Jr. Award, with several others recognized for their accomplishments.

Industry Watcher’s Digest

Buzzworthy developments of the past several days.

artificial intelligence warning united nations

Int’l panel: Safeguard human health against AI now—or risk losing the chance forever

As the world grapples with the potential downsides of generative AI, a global group of healthcare researchers is warning of health perils that could emanate from well beyond clinical settings.

1 in 3 cardiologists have been sued, though they often win when it happens

Overall, 31.2% of U.S. physicians say they have been sued. When looking at only cardiologists, the percentage is slightly higher.

The new MRI contrast agent gadopiclenol, sold under the trade names Elucirem and Vueway by Bracco and Guerbet, used 50% less gadolinium that current MRI agents. #RSNA22 #RSNA

New contrast agent earns positive safety classification from ACR

The ACR Committee on Drugs and Contrast Media stated that exposure to the gadolinium-based contrast agent represents a “sufficiently low or possibly nonexistent” risk to patients.

artificial intelligence AI deep learning

AI model predicts LVEF during routine coronary angiograms

The video-based deep neural network showed potential for limiting invasive exams and improving patient care.

Private equity-backed radiology provider Envision Healthcare to file for bankruptcy: Report

The move is expected to wipe out the entire investment of KKR, which first took the publicly traded physician group private in a 2018 $5.5B buyout.

Management

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics

Congressional candidate physician sues hospital and doctor for death of father

DEA wants to permanently anchor some COVID-era prescription regulations

FDA regulator examines AI's growing influence in cardiology